Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Deltagen and Pfizer establish target validation agreement

Jan. 29, 1999

Three patents covering drug formulation technology issued to Delsys

Jan. 28, 1999

Deltagen enters another gene target validation collaboration

Jan. 28, 1999

Deltagen to validate target genes for Roche Bioscience

Jan. 26, 1999

Results of animal studies indicate ability of GeneSwitch to regulate gene therapy

Jan. 22, 1999

MorphoSys enters licensing agreement with Chiron for HuCAL

Jan. 22, 1999

Pharmacopeia enters research collaboration with Pharmacia & Upjohn

Jan. 21, 1999

AxyS and RPR enter second collaborative agreement

Jan. 21, 1999

PDL issues further licenses under its antibody humanization patents

Jan. 20, 1999

Idun obtains rights to technology with application to HIV and other diseases

Jan. 20, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...